BRCA2 (Breast Cancer 2, Early Onset, BRCA2)
More information related to gene BRCA2.
Products related to BRCA2 Gene:
Recommended next Filters:
51 results :
- Type:
- gRNA
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_031542
- Species:
- Rat
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-PGK-Neo
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Neomycin
- Promoter:
- U6 Promoter, PGK Promoter
- Expression:
- Stable, Transient
- Type:
- gRNA
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_009765
- Species:
- Mouse
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-PGK-Neo
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Neomycin
- Promoter:
- U6 Promoter, PGK Promoter
- Expression:
- Stable, Transient
- Type:
- gRNA
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_000059
- Species:
- Human
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-PGK-Neo
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Neomycin
- Promoter:
- U6 Promoter, PGK Promoter
- Expression:
- Stable, Transient
- Type:
- gRNA
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_000059
- Species:
- Human
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-PGK-Neo
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Neomycin
- Promoter:
- U6 Promoter, PGK Promoter
- Expression:
- Stable, Transient
- Type:
- gRNA
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_000059
- Species:
- Human
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-PGK-Neo
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Neomycin
- Promoter:
- U6 Promoter, PGK Promoter
- Expression:
- Stable, Transient
- Type:
- gRNA + Cas9
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_031542
- Species:
- Rat
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Puromycin
- Promoter:
- U6 Promoter, SFFV Promoter
- Expression:
- Stable, Transient
- Type:
- gRNA + Cas9
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_009765
- Species:
- Mouse
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Puromycin
- Promoter:
- U6 Promoter, SFFV Promoter
- Expression:
- Stable, Transient
- Type:
- gRNA + Cas9
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_009765
- Species:
- Mouse
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Puromycin
- Promoter:
- U6 Promoter, SFFV Promoter
- Expression:
- Stable, Transient
- Type:
- gRNA + Cas9
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_009765
- Species:
- Mouse
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Puromycin
- Promoter:
- U6 Promoter, SFFV Promoter
- Expression:
- Stable, Transient
- Type:
- gRNA + Cas9
- Application:
- Protein Expression, Genome Editing with Engineered Nucleases
- Gene:
- Breast Cancer 2, Early Onset (BRCA2)
- NCBI Accession:
- NM_000059
- Species:
- Human
- Vector type:
- Lentiviral Vector
- Vector backbone:
- pLenti-U6-sgRNA-SFFV-Cas9-2A-Puro
- Resistance Gene:
- Ampicillin
- Selection Marker:
- Puromycin
- Promoter:
- U6 Promoter, SFFV Promoter
- Expression:
- Stable, Transient
Synonyms and alternative names related to BRCA2
- BRCA2, DNA repair associated (BRCA2)
- Breast cancer 2, early onset homolog (Brca2)
- BRCA2, DNA repair associated (Brca2)
- breast cancer 2, early onset (brca2)
- breast cancer 2, early onset (LOC584780)
- BRCA2, DNA repair associated (brca2)
- breast cancer 2, early onset (Brca2)
- 30169
- AI256696
- AW045498
- BcDNA:SD25109
- brca2
- BRCA2
- BRCC2
- brcc2
- BROVCA2
- brovca2
- CG13583
- CG13584
- CG30169
- dmbrca2
- Dmel\\CG30169
- FACD
- facd
- FAD
- fad
- FAD1
- fad1
- FANCB
- fancb
- FANCD
- FANCD1
- fancd1
- Fancd1
- GLM3
- PNCA2
- RAB163
Gene-IDs for different species
Protein level used designations for BRCA2
- BRCA1/BRCA2-containing complex, subunit 2
- breast and ovarian cancer susceptibility gene, early onset
- breast cancer 2 tumor suppressor
- breast cancer type 2 susceptibility protein
- fanconi anemia group D1 protein
- truncated breast and ovarian cancer susceptibility protein 2
- breast cancer 2, early onset homolog
- CG30169-PA
- Brca2-PA
- breast cancer 2, mutation 1, University of Wisconsin-Madison
- breast cancer susceptibility protein 2
- breast cancer type 2 susceptibility protein homolog
- fanconi anemia group D1 protein homolog
- breast and ovarian cancer susceptibility protein 2
- breast cancer 2, early onset
- breast cancer type 2 susceptibility protein-like